Switching to subtenon triamcinolone acetonide does not jeopardize the functional and anatomic outcomes of dexamethasone implant treated eyes with diabetic macular edema.

Borella, Ysé; Bertaud, Samuel; Tadayoni, Ramin; Bodaghi, Bahram; Dupas, Bénédicte; Touhami, Sara

Borella, Ysé; Bertaud, Samuel; Tadayoni, Ramin; Bodaghi, Bahram; Dupas, Bénédicte; Touhami, Sara.

Afiliação

Borella Y; Department of Ophthalmology, Sorbonne Université, Pitié-Salpêtrière University Hospital, 75013, Paris, France.
Bertaud S; Ophthalmology Department, Université de Paris, APHP, Hôpital Lariboisière, 75010, Paris, France.
Tadayoni R; Ophthalmology Department, Université de Paris, APHP, Hôpital Lariboisière, 75010, Paris, France.
Bodaghi B; Department of Ophthalmology, Sorbonne Université, Pitié-Salpêtrière University Hospital, 75013, Paris, France.
Dupas B; Ophthalmology Department, Université de Paris, APHP, Hôpital Lariboisière, 75010, Paris, France.
Touhami S; Department of Ophthalmology, Sorbonne Université, Pitié-Salpêtrière University Hospital, 75013, Paris, France. sara.touhami@aphp.fr.

Graefes Arch Clin Exp Ophthalmol ; 2024 Apr 26.

Article em En | MEDLINE | ID: mdl-38668853

Palavras-chave

Dexamethasone implant; Diabetic macular edema; Subtenon triamcinolone acetonide; Switch

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Graefes Arch Clin Exp Ophthalmol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google